1. Home
  2. CRNT vs CADL Comparison

CRNT vs CADL Comparison

Compare CRNT & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ceragon Networks Ltd.

CRNT

Ceragon Networks Ltd.

HOLD

Current Price

$2.24

Market Cap

206.7M

Sector

Technology

ML Signal

HOLD

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$4.93

Market Cap

280.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRNT
CADL
Founded
1996
1999
Country
Israel
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
206.7M
280.3M
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
CRNT
CADL
Price
$2.24
$4.93
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
7
Target Price
$4.00
$19.71
AVG Volume (30 Days)
344.4K
1.4M
Earning Date
05-06-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
58.62
EPS
N/A
N/A
Revenue
N/A
$125,000.00
Revenue This Year
$9.32
N/A
Revenue Next Year
$6.43
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.82
$4.25
52 Week High
$2.84
$8.69

Technical Indicators

Market Signals
Indicator
CRNT
CADL
Relative Strength Index (RSI) 47.28 43.81
Support Level $2.23 $4.57
Resistance Level $2.40 $6.16
Average True Range (ATR) 0.08 0.24
MACD -0.00 0.02
Stochastic Oscillator 38.71 45.19

Price Performance

Historical Comparison
CRNT
CADL

About CRNT Ceragon Networks Ltd.

Ceragon Networks Ltd is a wireless transport company in terms of unit shipments and wide distribution of its business, providing high-capacity wireless connectivity solutions to markets across various industries, mainly wireless (mobile) networks service providers. Geographically the company generates the key revenue from India. The company also has presence in North America, Europe, Africa, Asia-Pacific and Middle East, and Latin America. The company's products include IP-50 Platform, IP-20 Platform, Pointlink.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: